{"database":"EGA","file_versions":[],"scores":null,"additional":{"omics_type":["Genomics"],"study_type":["Other"],"full_dataset_link":["https://ega-archive.org/studies/EGAS00001006085"],"host":["EGA"],"description":["EGA study EGAS00001006085"],"dataset_title":["WGS of COH TNBC"],"repository":["EGA"],"category":["restricted"],"name_synonyms":["mamma, mammary region, formerly., Chs1, pepper syndrome, Breasts, Malignant Neoplasm, Malignancy, COH1, Neoplasms, Lobe of breast, mammary part of chest, Benign Neoplasm, Cyp15a2, Lactiferous gland, Benign Neoplasms, Cancers, Tumor, Brustdruese, Malignant, and prominent incisors, glandula mammaria, Coh, obesity, Malignant Neoplasms, Neoplasias, CYPIIA5, MT, Benign, Lobe of mammary gland, hypotonia, Neoplasm, Malignancies, Neoplasia, breast, Cancer, Tumors"],"description_synonyms":["mamma, Therapy, triple-receptor negative breast cancer, mammary region, Chs1, pepper syndrome, Breasts, Pharmacotherapy, COH1, chemotherapy, Lobe of breast, mammary part of chest, Cyp15a2, Lactiferous gland, pharmacotherapy, Pharmacotherapies, Brustdruese, and prominent incisors, TNBC, glandula mammaria, Coh, obesity, Chemotherapies, Drug, triple-negative breast cancer, WGS., CYPIIA5, response to platinum, Lobe of mammary gland, triple-negative breast carcinoma, hypotonia, Therapies, BRCA, Chemotherapy, pharmacologic therapy, Drug Therapies, breast, formerly"],"additional_accession":[]},"is_claimable":false,"name":"To determine the genomic profiles of Triple Negative Breast Cancers (COH cohort)","description":"Specific BRCA and immune configurations determine optimal response to platinum-based chemotherapy in triple negative breast and ovarian carcinomas (COH_TNBC_WGS)","dates":{"updated":"2023-12-11 11:14:47"},"accession":"EGAS00001006085","cross_references":{"TAXONOMY":["9606"],"EGA":["EGAD00001008617","EGAC00001002574"]}}